Patel Kinnari

Rocket Pharmaceuticals, Inc. · See Remarks

Patel Kinnari is listed in filings as See Remarks at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 22, 2025, including sale activity and purchase activity. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Aug 20, 2024 to May 22, 2025. Reported amounts are shown as $4.9K to $64.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Rocket Pharmaceuticals, Inc.RCKT$9.2k1.4k sharesSellMay 16, 2025$6.53$2.70
Rocket Pharmaceuticals, Inc.RCKTDisclosure amount unavailable21.1k sharesBuyApr 9, 2025--$2.70
Rocket Pharmaceuticals, Inc.RCKT$64k6.1k sharesSellFeb 21, 2025$10.58$2.70
Rocket Pharmaceuticals, Inc.RCKT$60k4.6k sharesSellNov 21, 2024$13.05$2.70
Rocket Pharmaceuticals, Inc.RCKT$74k4k sharesSellAug 16, 2024$18.50$2.70